A detailed history of Qtr Family Wealth, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Qtr Family Wealth, LLC holds 1,760 shares of BIIB stock, worth $294,888. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,760
Holding current value
$294,888
% of portfolio
0.12%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 29, 2025

BUY
$122.68 - $148.84 $215,916 - $261,958
1,760 New
1,760 $247 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $24.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Qtr Family Wealth, LLC Portfolio

Follow Qtr Family Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qtr Family Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qtr Family Wealth, LLC with notifications on news.